[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [RiskMitigation](https://github.com/mm80843/T3.5/tree/main/docs/RiskMitigation/index.md) >> Individual ID:PBN__RiskMitigation_586 

# __Utilization of molecular technologies__

## Category to which it belongs

* [Accelerate the shift to digitalization by embracing emerging technologies and implementing innovative solutions across various sectors.](https://github.com/mm80843/T3.5/blob/main/docs/PBNCategory/PBN__PBNCategory_343.md)

## Closest similar item

* [Screening technologies](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_635.md)
* [Development of bioinformatics tools](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_54.md)
* [UV-based technologies](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_994.md)
* [Adoption of emerging technologies](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_583.md)
* [Biosensors and nanoscale tools](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_811.md)
* [Research and development of antiviral technologies that are effective against a wider range of viruses.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2038.md)
* [Investment in research and development for vaccines and agent-specific drugs.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2069.md)
* [Use of new smart/innovative technologies](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_214.md)
* [Integration of new technologies (digital PCR, CSRPP, LOC/POC, biosensors)](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_878.md)
* [Select anti-microbial materials](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2864.md)

## Benefits linked to a risk

* [Faster vaccine development](https://github.com/mm80843/T3.5/blob/main/docs/Benef/PBN__Benef_580.md)

## Risks possibly mitigated by this Mitigation

* [Demand for vaccine development](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_423.md)

